Related Experiment Video
Updated: Jan 31, 2026

In Silico Clinical Trials for Cardiovascular Disease
Published on: May 27, 2022
Ivabradine for the Treatment of Cardiovascular Diseases
Tomomi Ide1, Kisho Ohtani1, Taiki Higo2
1Department of Experimental and Clinical Cardiovascular Medicine, Graduate School of Medical Sciences, Kyushu University.
Insights
Ivabradine, an inhibitor of the hyperpolarization-activated cyclic nucleotide-gated (HCN) 4 channel, effectively lowers heart rate (HR). This review details its mechanism and clinical effects in heart failure and other cardiac conditions.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Elevated heart rate (HR) is linked to adverse outcomes in cardiovascular diseases like hypertension, coronary artery disease, and heart failure (HF).
- The sinoatrial node's pacemaker activity, crucial for HR regulation, is influenced by the hyperpolarization-activated cyclic nucleotide-gated (HCN) 4 channel and its If current.
Purpose of the Study:
- To review the function of the HCN4 channel in cardiac pacemaking.
- To elucidate the mechanism of If inhibition by ivabradine.
- To summarize the pharmacological and clinical effects of ivabradine in cardiovascular diseases.
Main Methods:
- Literature review of HCN4 channel function.
- Analysis of ivabradine's mechanism of action.
- Synthesis of clinical trial data on ivabradine's efficacy and safety.
Main Results:
- HCN4 channels are critical for sinoatrial node automaticity and If current generation.
- Ivabradine selectively inhibits If current by binding to HCN4 channels.
- Ivabradine has demonstrated efficacy in reducing HR and improving outcomes in patients with chronic heart failure and stable angina.
Conclusions:
- Ivabradine represents a targeted therapy for heart rate reduction.
- Further research is warranted to explore its full potential in various cardiac arrhythmias and conditions, including atrial fibrillation.
Abstract:
Higher heart rate (HR) is independently related to worse outcomes in various cardiac diseases, including hypertension, coronary artery disease, and heart failure (HF). HR is determined by the pacemaker activity of cells within the sinoatrial node. The hyperpolarization-activated cyclic nucleotide-gated (HCN) 4 channel, one of 4 HCN isoforms, generates the If current and plays an important role in the regulation of pacemaker activity in the sinoatrial node. Ivabradine is a novel and only available HCN inhibitor, which can reduce HR and has been approved for stable angina and chronic HF in many countries other than Japan. In this review, we summarize the current knowledge of the HCN4 channel and ivabradine, including the function of HCN4 in cardiac pacemaking, the mechanism of action of If inhibition by ivabradine, and the pharmacological and clinical effects of ivabradine in cardiac diseases as HF, coronary artery disease, and atrial fibrillation.
More Related Videos
04:41Digital PCR for Quantifying Circulating MicroRNAs in Acute Myocardial Infarction and Cardiovascular Disease
Published on: July 3, 2018
10:11Fundus Photography as a Convenient Tool to Study Microvascular Responses to Cardiovascular Disease Risk Factors in Epidemiological Studies
Published on: October 22, 2014
Related Concept Videos
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Alzheimer's Disease: Treatment
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Overview of the Cardiovascular System
Heart
The heart is the central pump of the cardiovascular system that circulates blood throughout the body. It comprises two atria receiving the blood and two ventricles pumping blood out of the heart. Their rhythmic contractions, called heartbeats, ensure that blood flow remains continuous.
Blood Vessels
Blood...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents